Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Monday, October 21, 2024
  • 8:15 AM – 9:15 AM  
    49 - Source Plasma for Further Manufacture and Transfusion Medicine – Finding Common Ground
  • 8:15 AM – 9:15 AM  
    50 - A Multidisciplinary Approach to Delivering Comprehensive Care for Chronically Transfused Children and Adults with Sickle Cell Disease: An Overview of the Vanderbilt Sickle Cell Pathways Experience
  • 8:15 AM – 9:15 AM  
    51 - Clinical Relevance of ABO Antibodies and the New Era of Lectin Array Analysis of RBC ABO Glycosylation
  • 8:15 AM – 9:15 AM  
    52 - There’s a Blood Donation Bill Proposed to Require WHAT!?—Navigating the Legislative Proposal and Change Process
  • 8:15 AM – 9:15 AM  
    53 - Landsteiner-Alter Award and Lectureship
  • 8:15 AM – 9:15 AM  
    54 - Oral Abstract 5
  • 8:15 AM – 9:15 AM  
    55 - Oral Abstract 7
  • 8:15 AM – 12:15 PM  
    63 - CABP Exam Prep
  • 9:45 AM – 10:45 AM  
    56 - Management of Hematotoxicity from immune effector cell therapy and sickle cell disease gene therapy
  • 9:45 AM – 10:45 AM  
    57 - Should Rh Immune Globulin Be Administered After First Trimester Bleeding Events?
  • 9:45 AM – 10:45 AM  
    58 - Tibor Greenwalt Memorial Award and Lectureship
  • 9:45 AM – 10:45 AM  
    59 - Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster
  • 9:45 AM – 10:45 AM  
    60 - Oral Abstract 4
  • 9:45 AM – 10:45 AM  
    61 - Oral Abstracts 8
  • 9:45 AM – 10:45 AM  
    62 - Innovation and Challenges in Donor Recruitment
  • 2:00 PM – 3:00 PM  
    64 - Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System
  • 2:00 PM – 3:00 PM  
    66 - What is Interventional Transfusion Medicine / Hemotherapy? Why It May Represent a New Future for Transfusion Medicine.
  • 2:00 PM – 3:00 PM  
    67 - Paradigm Changes in Transfusion Medicine – Disaster Preparedness
  • 2:00 PM – 3:00 PM  
    68 - What is the status of the U.S. Blood Supply? Preliminary findings of the 2023 National Blood Collection and Utilization Survey
  • 2:00 PM – 3:00 PM  
    69 - Oral Abstract 3
  • 2:00 PM – 3:00 PM  
    70 - Oral Abstract 9
  • 2:00 PM – 3:00 PM  
    71 - Emily Cooley Memorial Award and Lectureship (Awards)
  • 3:30 PM – 5:00 PM  
    65 - Choose Your Own Adventure: Exploring the Depths of Serology and Peaks of Genomics
  • 3:30 PM – 5:00 PM  
    72 - Overview of Cell-Based Biologics Manufacturing as a Contracted Service
  • 3:30 PM – 5:00 PM  
    73 - Ask the FDA
  • 3:30 PM – 5:00 PM  
    74 - Innovation in Transfusion: How Creative Partnerships are Improving the Care of Critically Ill Trauma Patients
  • 3:30 PM – 5:00 PM  
    75 - Solve It! Scenarios in Apheresis and Cellular Therapy
  • 3:30 PM – 5:00 PM  
    76 - Cell Therapy: Creative Inventory Management & Discard
  • 3:30 PM – 5:00 PM  
    77 - Lyophilized, Stem-cell Derived, and Synthetic Platelet products are closer than you may think.
  • 3:30 PM – 5:00 PM  
    78 - Oral Abstract 10 - Spotlight
  • 5:30 PM – 6:30 PM  
    79 - Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation
  • 5:30 PM – 6:30 PM  
    80 - The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria
  • 5:30 PM – 6:30 PM  
    81 - Hemorrhage control and resuscitation: new tools.
  • 5:30 PM – 6:30 PM  
    82 - Turning Over Every Rock: Exploring Advanced Techniques in Platelet and Red Blood Cell Autoantibody Testing
  • 5:30 PM – 6:30 PM  
    83 - Oral Abstract 2
  • 5:30 PM – 6:30 PM  
    84 - Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America